FDA inspection
Vivex Biologics, Inc.: FDA inspection ending Jul 6, 2017
FDA inspection 1016973 · Voluntary Action Indicated (VAI) · Miami, FL
Key facts
| Inspection ID | 1016973 |
|---|---|
| Firm | Vivex Biologics, Inc. |
| FEI number | 1000113913 |
| Address | 1951 Nw 7th Ave Ste 200 |
| City | Miami |
| State | FL |
| ZIP | 33167 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Jul 6, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data